|

Wednesday April 29, 0:39 am Eastern Time
(BW)
(TX-MICROLIGHT) World-Renowned Orthopedic Laser Surgeon
Joins MicroLight's Advisory Board
Business
Editors/Health & Medical Writers
MISSOURI
CITY, Texas--(BUSINESS WIRE)--April 29, 2002--MicroLight
Corporation of America today announced that Dr. Chadwick F.
Smith has joined the company's medical advisory board.
Dr.
Smith is professor of orthopedic surgery at the University
of Southern California. He is also chairman of the medical
advisory board of U.S.C. Keck Medical School. Dr. Smith is
president elect of International Musculoskeletal Laser
Society, as well as chairman of S.I.C.O.T. (Societe
Internationale de Chirugie Orthopedique et de Tramatologie)
2002. He was responsible for starting the American Society
of Laser Therapy and establishing the six-hour C.M.E.
(Continuing Medical Education) Training Course for the safe
and proper use of low level lasers.
"I
am thrilled that the pioneer of orthopedic laser use has
agreed to join our medical advisory board. Dr. Smith is
known throughout the world as the foremost authority on
surgical and low level lasers," stated Mike Barbour,
president of MicroLight Corporation.
"A
new frontier opens up for the use of low level lasers for
the nonsurgical treatment of carpal tunnel syndrome. I am
very pleased to be a part of the medical advisory board of
MicroLight Corporation. These folks have spent 11 years and
millions of dollars in clinical research for the first of
many F.D.A. approvals to come. They are committed to basic
research and proper C.M.E. training. Over 300 clinicians
have used the company's patented ML 830 laser for the last
10 years. They will dominate this industry in America for
years to come," stated Dr. Chadwick Smith.
MicroLight
Corporation is the first company to get F.D.A. clearance to
market the patented low level laser for the nonsurgical
treatment of carpal tunnel syndrome. Carpal tunnel syndrome
is the number one repetitive stress injury problem in the
work force, costing the health care industry over $10
billion a year.
Back |